ITCI (Intra-Cellular Therapies Inc.) Rentabilitas dodolan miturut bathi resik

intracellulartherapies.com (ITCI) - logo korporat

Is it worth investing in a scalable neuro-drug business with global expansion potential? The revenue margin provides the answer, where -11.00 becomes the new value of the indicator. Growth in recurring revenues from Caplyta ensures high profits and free cash flow for Intra-Cellular Therapies (ITCI). However, there is a dependency on insurance coverage rates and the dominance of a single core product.

Margin resik intracellulartherapies.com (ITCI): kanggo periode 04.07.2022 - 13.04.2025

Intra-Cellular Therapies Inc. (ITCI) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:Intra-Cellular Therapies Inc., ITCI
Produk asil prodhuksi Intra-Cellular Therapies, Inc.

Scaling neuro-drug sales in the US directly impacts the cost management efficiency of Intra-Cellular Therapies (ITCI). This metric measures the share of net income in total revenue, reflecting the business's bottom-line profitability. Investors utilize this metric to assess the company's ability to convert market growth into actual income. Analyzing the company's net profit margin allows for the filtering out of short-term anomalies. A stable trend in this line confirms the resilience of the asset's fundamental value.

Analisis pesaing Intra-Cellular Therapies

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|Margin resik NERV|Margin dodolan resik ATHA|ADXN (Addex Therapeutics Ltd) - Tingkat bathi resik|Margin resik alzamend.com ALZN|Margin dodolan perusahaan Cyclerion Therapeutics (CYCN)|Protagenic - Margin dodolan resik|Tingkat bathi resik KTTA (Pasithea Therapeutics Corp)|CRGT: Margin dodolan resik|Avenue Therapeutics Inc. (ATXI) - Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics Inc.) - Margin dodolan resik|Margin dodolan resik Cara Therapeutics Inc|Margin resik Chromocell Therapeutics (CHRO)|Rentabilitas resik perusahaan ELYM|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel